Key result
Global deletion of Arginase 2 in mice abrogated high fat/high sucrose diet-induced increases in body and visceral adipose tissue weight, and prevented VAT inflammation and metabolic dysfunction.
Why the study?
Upregulated arginase is implicated in obesity and diabetes pathologies, prompting investigation into the role of arginase 2 in obesity-associated metabolic and vascular disorders.
Does Arginase 2 deletion prevent obesity-associated metabolic and vascular disorders in mice fed a high fat/high sucrose diet?
Does Arginase 2 deletion prevent obesity-associated metabolic and vascular disorders in mice fed a high fat/high sucrose diet?
Arginase 2 deletion protects against high fat/high sucrose diet-induced visceral adipose tissue inflammation, metabolic dysfunction, and vascular impairment in mice.
May identify Arginase 2 as a metabolic target; animal data leave open human translation.
Visceral adipose tissue (VAT) inflammation and metabolic dysregulation are key components of obesity-induced metabolic disease. Upregulated arginase, a ureahydrolase enzyme with two isoforms (A1-cytosolic and A2-mitochondrial), is implicated in pathologies associated with obesity and diabetes. This study examined A2 involvement in obesity-associated metabolic and vascular disorders. WT and globally deleted A2(−/−) or A1(+/−) mice were fed either a high fat/high sucrose (HFHS) diet or normal diet (ND) for 16 weeks. Increases in body and VAT weight of HFHS-fed WT mice were abrogated in A2−/−, but not A1+/−, mice. Additionally, A2−/− HFHS-fed mice exhibited higher energy expenditure, lower blood glucose, and insulin levels compared to WT HFHS mice. VAT and adipocytes from WT HFHS fed mice showed greater A2 expression and adipocyte size and reduced expression of PGC-1α, PPAR-γ, and adiponectin. A2 deletion blunted these effects, increased levels of active AMPK-α, and upregulated genes involved in fatty acid metabolism. A2 deletion prevented HFHS-induced VAT collagen deposition and inflammation, which are involved in adipocyte metabolic dysfunction. Endothelium-dependent vasorelaxation, impaired by HFHS diet, was significantly preserved in A2−/− mice, but more prominently maintained in A1+/− mice. In summary, A2 is critically involved in HFHS-induced VAT inflammation and metabolic dysfunction.
No takes yet. Share an insight, caveat, or question.
Atawia et al. (2019) studied Diet-induced obesity and metabolic disease. Arginase 2 (A2) deletion vs. Wild-type (WT) mice was evaluated on Body and visceral adipose tissue (VAT) weight, energy expenditure, blood glucose, and insulin levels. Global deletion of Arginase 2 in mice abrogated high fat/high sucrose diet-induced increases in body and visceral adipose tissue weight, and prevented VAT inflammation and metabolic dysfunction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: